Saudi Arabia Turkey And Egypt In Vitro Diagnostics Ivd Quality Control Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 867.09 Thousand |
 Market Size (Forecast Year) |
USD 1,260.66 Thousand |
 CAGR |
% |
| Major Markets Players |
>沙特阿拉伯、土耳其和埃及体外诊断 (IVD) 质量控制市场，按产品和服务（质量控制产品和服务质量控制服务）、应用（临床化学、免疫化学、血液学、分子诊断、凝血/止血、微生物学等）、部门（临床和非临床）、最终用户（临床实验室、学术和研究机构、血库、生物技术行业、制药行业等）划分 - 行业趋势和预测到 2030 年。
沙特阿拉伯、土耳其和埃及体外诊断 (IVD) 质量控制市场分析和规模
沙特阿拉伯、土耳其和埃及慢性病发病率的上升增加了市场需求。为获得更好的医疗服务而增加的医疗支出也促进了市场的增长。在这一关键时期，主要市场参与者专注于各种产品的发布和批准。此外，质量控制服务的改善也促进了 IVD 质量控制市场的需求增长。
沙特阿拉伯、土耳其和埃及体外诊断 (IVD) 质量控制市场预计将在 2023 年至 2030 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2023 年至 2030 年的预测期内，该市场以 4.8% 的复合年增长率增长，预计到 2030 年将从 2022 年的 867.09 万美元达到 1,260.66 万美元。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（千美元） |
|
涵盖的领域 |
产品和服务（质量控制产品和质量控制服务）、应用（临床化学、免疫化学、血液学、分子诊断、凝血/止血、微生物学等）、行业（临床和非临床）、最终用户（临床实验室、学术和研究机构、血库、生物技术行业、制药行业等） |
|
覆盖国家 |
沙特阿拉伯、土耳其和埃及 |
|
涵盖的市场参与者 |
在市场上开展业务的主要公司包括 Bio-Rad Laboratories, Inc、Siemens Healthcare Private Limited、Sysmex Europe SE、Randox Laboratories Ltd.、Sera Care、Thermo Fisher Scientific Inc.、Beckman Coulter, Inc.、Technopath Clinical Diagnostics、DiaSorin SpA、Agappe Diagnostics Ltd 和 Spectrum Diagnostics 等。 |
市场定义
体外诊断产品是指用于诊断疾病或其他状况（包括确定健康状况）的试剂、仪器和系统，目的是治愈、缓解、治疗或预防疾病或其后遗症。此类产品用于收集、制备和检查从人体采集的样本。
IVD质控品是用来验证IVD测试系统可靠性的样品/材料，以确保测试结果的准确性，并评估环境条件和操作员的表现等因素对测试结果的影响。此外，它们还可用于监测患者的健康状况，治疗疾病，并使医疗专业人员能够为患者确定最有效的治疗程序或疗法。
体外诊断 (IVD) 质量控制市场动态
本节旨在了解市场驱动因素、机遇、限制和挑战。以下内容将详细讨论所有这些内容：
驱动程序
- 沙特阿拉伯、土耳其和埃及慢性病患病率上升
全球范围内，慢性疾病和病症呈上升趋势。人口老龄化和久坐不动的生活方式导致长期健康问题稳步增加。慢性病和传染病的日益流行促使主要市场参与者推出快速诊断和检测工具。此外，自我检测和即时诊断设备的日益普及进一步加速了全球体外诊断设备的增长
因此，预计慢性病数量的增加将在不久的将来显著加速 IVD 质量控制市场的增长。
- 实验室和医院越来越多地采用质量控制解决方案
患者样本的实验室检测可能是一个复杂的过程，取决于临床分析、微生物学研究或血库检测等临床实验室方面。质量控制 (QC) 是影响实验室检测的最重要因素之一 - 它确保患者样本结果的精确度和准确性。质量控制样本的完整性对于整体质量管理以及满足能力测试要求都很重要。
因此，实验室和医院越来越多地采用质量控制解决方案预计将推动市场增长。
机会
-
组织间战略收购和合作增多
最近，不同的组织正在寻求合作和协作，以开发对检测疾病至关重要的体外诊断产品。不仅如此，借助合作伙伴关系和协议，两家公司还可以开发一套有助于检测疾病的新技术和平台。
借助长期协议，两家公司可以根据市场消费者需求提供尺寸定价的体外诊断产品。这种伙伴关系和相互协议不仅使两家公司受益，而且还为市场增长创造了许多机会。
-
研发活动不断增加
在全球范围内，由于公共卫生支出和经济表现，研发支出不断增加。然而，医疗保健行业在研发支出方面位居所有行业第二位。医疗保健支出的增加进一步带来了更好的研发机会。因此，它增加了整个地区对 IVD 监管事务外包服务的需求。
限制/挑战
- IVD质量控制和维护成本高
体外诊断 (IVD) 是对从人体采集的血液或组织等样本进行的测试。体外诊断可以检测疾病或其他状况，并可用于监测一个人的整体健康状况，以帮助治愈、治疗或预防疾病。
IVD是针对源自身体样本（包括血液和组织活检）的分析物进行的，可单独使用或与临床研究结合使用，被视为实现高质量医疗结果的重要工具，因此，维护IVD和IVD设备的质量控制对于进行准确测试而言成本很高。
因此，IVD维护成本的上升已经成为服务企业的决定性因素，在一定程度上进一步抑制了市场的增长。
- 沙特阿拉伯、土耳其和埃及的体外诊断（IVD）法规十分严格
随着老龄人口的增长和多种慢性疾病的出现，全球 IVD 的使用正在迅速增加，这些疾病可以通过早期诊断和及时治疗来预防。同时，市场上的 IVD 设备参与者必须遵守某些法规，才能获得上级部门的批准，才能在某个地区推出产品。必须遵循这些严格的指导方针，这是所有步骤中最困难的任务之一。各种医疗器械的上市前批准因国家而异。
因此，严格的产品审批规则和规定限制了市场的增长。
近期发展
- 2023 年 2 月，领先的医疗技术公司西门子医疗与领先的诊断服务提供商 Unilabs 宣布了一项价值超过 20 万欧元的多年期协议。Unilabs 已投资西门子医疗的顶尖技术，并将购买 400 多台实验室分析仪，以进一步改善其实验室基础设施，为客户提供无与伦比的服务。此次合作有助于最新的诊断测试基础设施，从而改善患者的护理。
- 2021 年 7 月，全球科学服务领导者赛默飞世尔科技宣布与 Ortho Clinical Diagnostics 合作，推广和分销用于 Ortho Clinical Diagnostics VITROS 分析仪的 Thermo Scientific MAS 质量控制和 LabLink xL 质量保证软件。此举帮助该公司提升了其在全球市场的影响力。
沙特阿拉伯、土耳其和埃及体外诊断 (IVD) 质量控制市场范围
沙特阿拉伯、土耳其和埃及体外诊断 (IVD) 质量控制市场分为四个显著的细分市场，例如产品和服务、应用、类型、行业和最终用户。这些细分市场之间的增长将帮助您分析行业中微弱的增长细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
產品與服務
- 质量控制产品
- 质量控制服务
根据产品和服务，沙特阿拉伯、土耳其和埃及体外诊断 (IVD) 质量控制市场分为质量控制产品和质量控制服务。
应用
- 临床化学
- 免疫化学
- 血液学
- 分子诊断
- 凝血/止血
- 微生物学
- 其他的
根据应用，沙特阿拉伯、土耳其和埃及的体外诊断 (IVD) 质量控制市场细分为临床化学、免疫化学、血液学、分子诊断、凝血/止血、微生物学等。
部门
- 临床
- 非临床
根据行业，沙特阿拉伯、土耳其和埃及的体外诊断 (IVD) 质量控制市场分为临床和非临床。
最终用户
- 临床实验室
- 学术及研究机构
- 血库
- 生物科技产业
- 制药行业
- 其他的
根据最终用户，沙特阿拉伯、土耳其和埃及体外诊断 (IVD) 质量控制市场细分为临床实验室、学术和研究机构、血库、生物技术行业、制药行业等。
竞争格局和体外诊断 (IVD) 质量控制市场份额分析
体外诊断 (IVD) 质量控制市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对共济失调市场的关注有关。
体外诊断 (IVD) 质量控制市场的一些主要参与者包括 Bio-Rad Laboratories, Inc、Siemens Healthcare Private Limited、Sysmex Europe SE、Randox Laboratories Ltd.、Sera Care、Thermo Fisher Scientific Inc.、Beckman Coulter, Inc.、Technopath Clinical Diagnostics、DiaSorin SpA、Agappe Diagnostics Ltd 和 Spectrum Diagnostics 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SAUDI ARABIA PRODUCTS AND SERVICES, LIFELINE CURVE
2.8 EGYPT PRODUCTS AND SERVICES, LIFELINE CURVE
2.9 TURKEY PRODUCTS AND SERVICES, LIFELINE CURVE
2.1 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.11 DBMR MARKET POSITION GRID
2.12 MARKET TESTING TYPE COVERAGE GRID
2.13 VENDOR SHARE ANALYSIS
2.14 SECONDARY SOURCES
2.15 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL'S MODEL
4.2 PORTER'S 5 FORCES
4.3 INDUSTRY INSIGHTS
5 REGULATORY GUIDELINES FOR IN VITRO DIAGNOSTICS QUALITY CONTROL
5.1 REGULATIONS IN SAUDI ARABIA
5.2 REGULATIONS IN TURKEY
5.3 REGULATIONS IN EGYPT
5.3.1 MEDICAL DEVICE REGISTRATION IN EGYPT, THE PROCESS IN BRIEF:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF CHRONIC DISEASES ACROSS SAUDI ARABIA, TURKEY, AND EGYPT
6.1.2 RISING ADOPTION OF QUALITY CONTROL SOLUTIONS IN LABORATORIES AND HOSPITALS
6.1.3 ADVANCEMENTS IN TECHNOLOGY LEADING TO THE DEVELOPMENT OF NEW AND ADVANCED DIAGNOSTIC PRODUCTS
6.1.4 RISING USE OF QUALITY CONTROL IN MOLECULAR DIAGNOSTICS
6.2 RESTRAINTS
6.2.1 HIGH COST RELATED TO QUALITY CONTROL AND MAINTENANCE OF IVD
6.2.2 STRINGENT REGULATIONS REGARDING IVD IN SAUDI ARABIA, TURKEY, AND EGYPT
6.3 OPPORTUNITIES
6.3.1 RISE IN STRATEGIC ACQUISITION AND PARTNERSHIP AMONG ORGANIZATIONS
6.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES
6.4 CHALLENGES
6.4.1 LACK OF INFRASTRUCTURE IN HEALTHCARE SERVICE
6.4.2 SHORTAGE OF SKILLED PERSONNEL FOR HANDLING QUALITY CONTROL OF IN VITRO DIAGNOSTIC DEVICES.
7 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT AND SERVICES
7.1 OVERVIEW
7.2 QUALITY CONTROL PRODUCTS
7.2.1 SERUM/PLASMA-BASED CONTROL
7.2.2 WHOLE BLOOD-BASED CONTROLS
7.2.3 URINE-BASED CONTROLS
7.2.4 OTHER CONTROLS
7.2.5 INTERNAL QUALITY CONTROL
7.2.6 EXTERNAL QUALITY CONTROL
7.3 QUALITY CONTROL SERVICES
8 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 CLINICAL CHEMISTRY
8.3 IMMUNOCHEMISTRY
8.4 HEMATOLOGY
8.5 MOLECULAR DIAGNOSTICS
8.5.1 QUALITY CONTROL PRODUCTS
8.5.1.1 INTERNAL QUALITY CONTROL
8.5.1.2 EXTERNAL QUALITY CONTROL
8.5.2 QUALITY CONTROL SERVICES
8.6 COAGULATION/HEMOSTASIS
8.7 MICROBIOLOGY
8.8 OTHERS
9 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR
9.1 OVERVIEW
9.2 CLINICAL
9.3 NON-CLINICAL
10 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER
10.1 OVERVIEW
10.2 CLINICAL LABORATORIES
10.3 ACADEMIC AND RESEARCH INSTITUTES
10.4 PHARMACEUTICAL INDUSTRY
10.5 BIOTECHNOLOGY INDUSTRY
10.6 BLOOD BANKS
10.7 OTHERS
11 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: SAUDI ARABIA
11.2 COMPANY SHARE ANALYSIS: EGYPT
11.3 COMPANY SHARE ANALYSIS: TURKEY
12 SWOT ANALYSIS
13 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, COMPANY PROFILES
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 SIEMENS HEALTHCARE GMBH
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENT
13.3 BIO-RAD LABORATORIES, INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENT
13.4 BECKMAN COULTER, INC.
13.4.1 COMPANY SNAPSHOT
13.4.2 PRODUCT PORTFOLIO
13.4.3 RECENT DEVELOPMENT
13.5 SYSMEX CORPORATION
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENT
13.6 AGAPPE DIAGNOSTICS LTD
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENT
13.7 DIASORIN MOLECULAR LLC.
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 RANDOX LABORATORIES LTD.
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENT
13.9 SERA CARE
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENT
13.1 SPECTRUM DIAGNOSTICS
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT DEVELOPMENT
13.11 TECHNOPATH CLINICAL DIAGNOSTICS
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENT
14 QUESTIONNAIRE
15 RELATED REPORTS
图片列表
FIGURE 1 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: SEGMENTATION
FIGURE 2 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: DATA TRIANGULATION
FIGURE 3 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: DROC ANALYSIS
FIGURE 4 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COUNTRY MARKET ANALYSIS
FIGURE 5 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COUNTRY MARKET ANALYSIS
FIGURE 6 TURKEYS IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COUNTRY MARKET ANALYSIS
FIGURE 7 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 8 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: DBMR MARKET POSITION GRID
FIGURE 10 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 11 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: VENDOR SHARE ANALYSIS
FIGURE 12 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: SEGMENTATION
FIGURE 13 RISING PREVALENCE OF CHRONIC DISEASES ACROSS SAUDI ARABIA IS EXPECTED TO DRIVE THE SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN THE FORECAST PERIOD
FIGURE 14 RISING ADOPTION OF QUALITY CONTROL SOLUTIONS IN LABORATORIES AND HOSPITALS IS EXPECTED TO DRIVE THE TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN THE FORECAST PERIOD IN THE FORECAST PERIOD
FIGURE 15 ADVANCEMENTS IN TECHNOLOGY LEADING TO THE DEVELOPMENT OF NEW AND ADVANCED DIAGNOSTIC PRODUCTS ARE EXPECTED TO DRIVE THE EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN THE FORECAST PERIOD IN THE FORECAST PERIOD
FIGURE 16 THE PRODUCT AND SERVICES TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN 2023 & 2030
FIGURE 17 THE PRODUCT AND SERVICES TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN 2023 & 2030
FIGURE 18 THE PRODUCT AND SERVICES TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN 2023 & 2030
FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET
FIGURE 20 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2022
FIGURE 21 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2022
FIGURE 22 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2022
FIGURE 23 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2023-2030 (USD THOUSAND)
FIGURE 24 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2023-2030 (USD THOUSAND)
FIGURE 25 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2023-2030 (USD THOUSAND)
FIGURE 26 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, CAGR (2023-2030)
FIGURE 27 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, CAGR (2023-2030)
FIGURE 28 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, CAGR (2023-2030)
FIGURE 29 SAUDI ARABIA, TURKEY AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, LIFELINE CURVE
FIGURE 30 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, LIFELINE CURVE
FIGURE 31 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, LIFELINE CURVE
FIGURE 32 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2022
FIGURE 33 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2022
FIGURE 34 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2022
FIGURE 35 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 36 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 37 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 38 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, CAGR (2023-2030)
FIGURE 39 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, CAGR (2023-2030)
FIGURE 40 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, CAGR (2023-2030)
FIGURE 41 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, LIFELINE CURVE
FIGURE 42 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, LIFELINE CURVE
FIGURE 43 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, LIFELINE CURVE
FIGURE 44 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2022
FIGURE 45 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2022
FIGURE 46 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2022
FIGURE 47 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2023-2030 (USD THOUSAND)
FIGURE 48 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2023-2030 (USD THOUSAND)
FIGURE 49 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2023-2030 (USD THOUSAND)
FIGURE 50 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, CAGR (2023-2030)
FIGURE 51 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, CAGR (2023-2030)
FIGURE 52 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, CAGR (2023-2030)
FIGURE 53 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, LIFELINE CURVE
FIGURE 54 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, LIFELINE CURVE
FIGURE 55 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, LIFELINE CURVE
FIGURE 56 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2022
FIGURE 57 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2022
FIGURE 58 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2022
FIGURE 59 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 60 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 61 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 62 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, CAGR (2023-2030)
FIGURE 63 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, CAGR (2023-2030)
FIGURE 64 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, CAGR (2023-2030)
FIGURE 65 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, LIFELINE CURVE
FIGURE 66 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, LIFELINE CURVE
FIGURE 67 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, LIFELINE CURVE
FIGURE 68 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COMPANY SHARE 2022 (%)
FIGURE 69 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COMPANY SHARE 2022 (%)
FIGURE 70 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
